A citation-based method for searching scientific literature

Simeon I Taylor, Jenny E Blau, Kristina I Rother, Amber L Beitelshees. Lancet Diabetes Endocrinol 2019
Times Cited: 18







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Nicole A Sherry, Wei Chen, Jake A Kushner, Mariela Glandt, Qizhi Tang, Sue Tsai, Pere Santamaria, Jeffrey A Bluestone, Anne-Marie B Brillantes, Kevan C Herold. Endocrinology 2007
138
5

Combination Immunotherapy for Type 1 Diabetes.
Robert N Bone, Carmella Evans-Molina. Curr Diab Rep 2017
9
11

Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A Dimeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Diabetes Care 2014
107
5

Obesity and diabetes-Not only a simple link between two epidemics.
Agata Chobot, Katarzyna Górowska-Kowolik, Magdalena Sokołowska, Przemysława Jarosz-Chobot. Diabetes Metab Res Rev 2018
35
5

Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.
Michelle Rosenzwajg, Randa Salet, Roberta Lorenzon, Nicolas Tchitchek, Alexandra Roux, Claude Bernard, Jean-Claude Carel, Caroline Storey, Michel Polak, Jacques Beltrand,[...]. Diabetologia 2020
5
20


B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Yan Xiu, Carmen P Wong, Jean-David Bouaziz, Yasuhito Hamaguchi, Yaming Wang, Shannon M Pop, Roland M Tisch, Thomas F Tedder. J Immunol 2008
155
5

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.
Michael J Haller, Desmond A Schatz, Jay S Skyler, Jeffrey P Krischer, Brian N Bundy, Jessica L Miller, Mark A Atkinson, Dorothy J Becker, David Baidal, Linda A DiMeglio,[...]. Diabetes Care 2018
36
5

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
Mark R Rigby, Kristina M Harris, Ashley Pinckney, Linda A DiMeglio, Marc S Rendell, Eric I Felner, Jean M Dostou, Stephen E Gitelman, Kurt J Griffin, Eva Tsalikian,[...]. J Clin Invest 2015
131
5

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Adrian Villalba, Silvia Rodriguez-Fernandez, David Perna-Barrull, Rosa-Maria Ampudia, Laia Gomez-Muñoz, Irma Pujol-Autonell, Eva Aguilera, Mireia Coma, Mary Cano-Sarabia, Federico Vázquez,[...]. Front Endocrinol (Lausanne) 2020
4
25

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Júlio C Voltarelli, Carlos E B Couri, Ana B P L Stracieri, Maria C Oliveira, Daniela A Moraes, Fabiano Pieroni, Marina Coutinho, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2007
351
5


Enteroviral Infections as a Trigger for Type 1 Diabetes.
Teresa Rodriguez-Calvo. Curr Diab Rep 2018
9
11

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
Ezio Bonifacio, Anette-G Ziegler, Georgeanna Klingensmith, Edith Schober, Polly J Bingley, Marietta Rottenkolber, Anke Theil, Anne Eugster, Ramona Puff, Claudia Peplow,[...]. JAMA 2015
91
5

The viral paradigm in type 1 diabetes: Who are the main suspects?
Teresa Rodriguez-Calvo, Somayeh Sabouri, Florence Anquetil, Matthias G von Herrath. Autoimmun Rev 2016
33
5

Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Mark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, Dorothy J Becker, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Jennifer B Marks, Paula F McGee, Antoinette M Moran,[...]. N Engl J Med 2009
621
5

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.
Agnès Hartemann, Gilbert Bensimon, Christine A Payan, Sophie Jacqueminet, Olivier Bourron, Nathalie Nicolas, Michèle Fonfrede, Michelle Rosenzwajg, Claude Bernard, David Klatzmann. Lancet Diabetes Endocrinol 2013
226
5

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.
Lucy Mastrandrea, Jihnhee Yu, Torsten Behrens, John Buchlis, Christine Albini, Shannon Fourtner, Teresa Quattrin. Diabetes Care 2009
142
5

Progress in immune-based therapies for type 1 diabetes.
M von Herrath, M Peakman, B Roep. Clin Exp Immunol 2013
48
5

Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
S J Cleland, B M Fisher, H M Colhoun, N Sattar, J R Petrie. Diabetologia 2013
98
5

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Nicole Sherry, William Hagopian, Johnny Ludvigsson, Sunil M Jain, Jack Wahlen, Robert J Ferry, Bruce Bode, Stephen Aronoff, Christopher Holland, David Carlin,[...]. Lancet 2011
289
5

Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.
Husam Ghanim, Manav Batra, Kelly Green, Sanaa Abuaysheh, Jeanne Hejna, Antione Makdissi, Robert Borowski, Nitesh D Kuhadiya, Ajay Chaudhuri, Paresh Dandona. Diabetes Obes Metab 2020
4
25

The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials.
Lawrence A Leiter, Stephen C Bain, Deepak L Bhatt, John B Buse, C David Mazer, Richard E Pratley, Søren Rasmussen, Maria Sejersten Ripa, Hrvoje Vrazic, Subodh Verma. Diabetes Obes Metab 2020
4
25

Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.
Tom L Van Belle, Stefan Nierkens, Ramon Arens, Matthias G von Herrath. Immunity 2012
41
5

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, Catherine Cowie, Jerry P Palmer, Carla Greenbaum, David Cuthbertson, Lisa E Rafkin-Mervis, H Peter Chase, Ellen Leschek. Diabetes Care 2005
376
5

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Kevan C Herold, Brian N Bundy, S Alice Long, Jeffrey A Bluestone, Linda A DiMeglio, Matthew J Dufort, Stephen E Gitelman, Peter A Gottlieb, Jeffrey P Krischer, Peter S Linsley,[...]. N Engl J Med 2019
157
5

Infliximab in the treatment of Crohn disease and type 1 diabetes.
Katharina Timper, Petr Hruz, Christoph Beglinger, Marc Y Donath. Diabetes Care 2013
10
10

Long-term viability through selective permeability.
Ken Coppieters, Louise Winkel, Matthias von Herrath. Nat Biomed Eng 2020
1
100

Relationship between BMI and age at diagnosis of type 1 diabetes in a Mediterranean area in the period of 1990-2004.
Marga Giménez, Eva Aguilera, Conxa Castell, Nuria de Lara, Joana Nicolau, Ignacio Conget. Diabetes Care 2007
18
5

Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Nitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, Paresh Dandona. Diabetes Obes Metab 2019
1
100

Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
2
50

The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta-analysis.
Saniya Tandon, Salma Ayis, David Hopkins, Seeromanie Harding, Marietta Stadler. Diabetes Obes Metab 2021
1
100

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
Michael J Haller, S Alice Long, J Lori Blanchfield, Desmond A Schatz, Jay S Skyler, Jeffrey P Krischer, Brian N Bundy, Susan M Geyer, Megan V Warnock, Jessica L Miller,[...]. Diabetes 2019
28
5


Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.
Christian Hundhausen, Alena Roth, Elizabeth Whalen, Janice Chen, Anya Schneider, S Alice Long, Shan Wei, Rebecca Rawlings, MacKenzie Kinsman, Stephen P Evanko,[...]. Sci Transl Med 2016
40
5


Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Christian S Frandsen, Thomas F Dejgaard, Jens J Holst, Henrik U Andersen, Birger Thorsteinsson, Sten Madsbad. Diabetes Care 2015
50
5

Correction of diabetic alterations by glucokinase.
T Ferre, A Pujol, E Riu, F Bosch, A Valera. Proc Natl Acad Sci U S A 1996
110
5

Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.
Pål R Njølstad, Jørn V Sagen, Lise Bjørkhaug, Stella Odili, Naim Shehadeh, Doua Bakry, S Umit Sarici, Faruk Alpay, Janne Molnes, Anders Molven,[...]. Diabetes 2003
111
5

Increasing Hospitalizations for DKA: A Need for Prevention Programs.
Priyathama Vellanki, Guillermo E Umpierrez. Diabetes Care 2018
15
6

Competitive inhibition of liver glucokinase by its regulatory protein.
A Vandercammen, E Van Schaftingen. Eur J Biochem 1991
85
5

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies.
Anne L Peters, Darren K McGuire, Thomas Danne, Jake A Kushner, Helena W Rodbard, Ketan Dhatariya, Sangeeta Sawhney, Phillip Banks, Wenjun Jiang, Michael J Davies,[...]. Diabetes Care 2020
2
50

Molecular physiology of mammalian glucokinase.
P B Iynedjian. Cell Mol Life Sci 2009
203
5



Molecular targeting of the GK-GKRP pathway in diabetes.
Clarence Hale, David J Lloyd, Andrea Pellacani, Murielle M Véniant. Expert Opin Ther Targets 2015
8
12

Linkage of type 2 diabetes to the glucokinase gene.
A T Hattersley, R C Turner, M A Permutt, P Patel, Y Tanizawa, K C Chiu, S O'Rahilly, P J Watkins, J S Wainscoat. Lancet 1992
307
5

Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus.
P Froguel, M Vaxillaire, F Sun, G Velho, H Zouali, M O Butel, S Lesage, N Vionnet, K Clément, F Fougerousse. Nature 1992
512
5

Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase.
N de la Iglesia, M Veiga-da-Cunha, E Van Schaftingen, J J Guinovart, J C Ferrer. FEBS Lett 1999
74
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.